CAS 1253186-49-0

2,6-Difluoro-N-[1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1H-pyrazol-3-yl]benzamide

Kontrolliertes Produkt

CAS: 1253186-49-0

2,6-Difluoro-N-[1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1H-pyrazol-3-yl]benzamide is a blocker of voltage gated calcium channels. It is a selective inhibitor of T lymphocytes and monocytes. This drug is also an inhibitor of the pyrazole channel. The amino groups in this molecule bind to the channel and block it, thereby inhibiting calcium flow into the cell. 2,6-Difluoro-N-[1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1H-pyrazol-3-yl]benzamide blocks cytokines that are released by human immune cells, which may be responsible for its antiinflammatory effects.

Formel: C₁₈H₁₁F₆N₃O

Reinheit: Min. 95%

Molekulargewicht: 399.29 g/mol

Ref: 3D-FD101575

GSK-5498A

CAS: 1253186-49-0

GSK-5498A: Selective CARC blocker, inhibits release of mediators from mast cells and cytokines from T-cells (IC50, 1 μM).

Formel: C₁₈H₁₁F₆N₃O

Farbe und Form: Solid

Molekulargewicht: 399.29

Ref: TM-T11473